News Center
Qiyuan Pharmaceutical through the customs AEO advanced enterprise certification
2022-12-22Return list
On December 12, 2022, Qiyuan Pharmaceutical obtained AEO Advanced Certification Enterprise Certificate issued by Yinchuan Customs.
At the beginning of 2021, after early communication with Yinchuan Customs and internal assessment, Qiyuan Pharmaceutical decided to start the AEO Advanced certification project in accordance with the requirements of the Credit Management Measures for Enterprises Registered and Filed by the Customs of the People's Republic of China and the Standards for Advanced Certification Enterprises by the Customs. And set up the Marketing Department led by purchasing department, administration department, computer management center, safety production department, finance department, quality technology center and 307 workshop and other personnel to participate in the Customs certification group. The team checks the certification standards in detail, revises and improves the certification system documents and records, and corrects the information system hardware and software, so as to comprehensively promote the work related to AEO advanced certification.
On November 14, 2022, Qiyuan Pharmaceutical submitted the final application materials. The Customs certification expert group carefully reviewed the internal control, financial condition, compliance with the law, trade security and other aspects of Qiyuan Pharmaceutical through field investigation, data review, inquiry and defense, and finally approved Qiyuan Pharmaceutical to pass AEO advanced certification.
Customs AEO advanced certification is the highest credit rating for international trade enterprises recognized by customs of all countries. It requires enterprises to have a sound management system, healthy financial indicators, and perfect conditions for cargo safety management. Through the certification, enterprises can enjoy a series of customs facilitation measures such as the minimum customs inspection rate, exemption of guarantees and priority clearance, further reducing the operation costs of enterprises. The acquisition of this global trade "green pass" undoubtedly infuses new momentum into the international market for Qiyuan Pharmaceutical.
